Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123341
Filing Date
2024-11-07
Accepted
2024-11-07 16:12:11
Documents
61
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lbph-20240930.htm   iXBRL 10-Q 2395121
2 EX-31.1 lbph-ex31_1.htm EX-31.1 17611
3 EX-31.2 lbph-ex31_2.htm EX-31.2 17653
4 EX-32.1 lbph-ex32_1.htm EX-32.1 16045
  Complete submission text file 0000950170-24-123341.txt   9966996

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lbph-20240930.xsd EX-101.SCH 970540
64 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20240930_htm.xml XML 2365648
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

EIN.: 845009619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40192 | Film No.: 241435808
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)